DCT

5:13-cv-04057

Gilead Sciences Inc v. Merck & Co Inc

General

Filed

08/30/13

Cause of ActionDeclaratory Judgment

SectorBiotech

Status

Closed (08/02/17)

Patent Owner

Operating Company (L)

PACER5:13-cv-04057

Appeals16-2302, 16-2615, 18-1017

CourtN.D. California

Judge	Period	PO Win Rate
Beth L. Freeman	--	11%

Plaintiff

Party

Name	Ratings
Gilead Sciences Inc	L3B

Attorney

Name	Ratings
Fish & Richardson	L5A
Juanita R. Brooks	L5A
Jonathan E. Singer	L5A
Tamara Fraizer	L5A
William C. Shear	L5B
John M. Farrell	L5C
Michael E. Florey	L5C
Robert M. Oakes	L4A
Gregory R. Booker	L4A
Douglas E. McCann	L4A
Martina T. Hufnal	L4C
Joseph B. Warden	L4C
Kelly A. Del Dotto	L4C
Rebecca C. Grant	L3C
Elizabeth M. Flanagan	L3C
Matthew L. Levine	---- --

Defendant

Party

Name	Ratings
Merck & Co Inc	L5A
Merck Sharp & Dohme LLC	L5A
Isis Pharmaceuticals Inc	---- --

Attorney

Name	Ratings
Sidley Austin LLP	L5B
David T. Pritikin	L5A
M. Patricia Thayer	L5D
Todd L. Krause	L4A
S. Isaac Olson	L3B
Sue Wang	L1D
Durie Tangri LLP	L3B
Joshua H. Lerner	L4D
Laura E. Miller	L3C
Williams & Connolly LLP	L3C
Bruce R. Genderson	L5A
Sanjiv P. Laud	L4C
Jessamyn S. Berniker	L4C
Stanley E. Fisher	L4C
Jessica P. Ryen	L4C
Jessica B. Rydstrom	L4-- --
Fried Frank Harris Shriver & Jacobson LLP	L2D
James W. Dabney	L4D
Randy C. Eisensmith	L4D
Stephen S. Rabinowitz	L4D
Wanda French-Brown	L3B
Naz Wehrli	L2C
Hughes Hubbard & Reed LLP	L1C
Patrice P. Jean	L4D
Stefanie Lopatkin	L3C
David L. Lansky	L3C
Mitchell Epner	L3E